Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 20/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123646 | 1.00 | ELANE (0.79) | ELANECYP2C9CYP3A4CYP2C19 | |
| SCHEMBL8010841 | 0.96 | ELANE (0.76) | ELANECYP2C9CYP3A4CYP2C19 | |
| SCHEMBL18839888 | 0.92 | ELANE (0.83) | ELANECYP2C9CYP3A4 | |
| SCHEMBL123593 | 0.92 | ELANE (0.83) | ELANECYP2C9CYP3A4 | |
| SCHEMBL3723154 | 0.90 | ELANE (0.79) | ELANECYP2C9CYP3A4 | |
| SCHEMBL124551 | 0.90 | ELANE (0.79) | ELANECYP2C9CYP3A4 | |
| SCHEMBL12859002 | 0.89 | ELANE (0.72) | ELANECYP2C19 | |
| SCHEMBL123019 | 0.89 | ELANE (0.78) | ELANECYP2C9CYP3A4CYP2C19 | |
| SCHEMBL125403 | 0.89 | ELANE (0.83) | ELANECYP2C9CYP3A4CYP2C19 | |
| SCHEMBL3663656 | 0.89 | ELANE (1.00) | ELANECYP2C9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3373936-A1 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS | Bayer Pharma Aktiengesellschaft (DE) | 2018-09-19 | — | — | EP | claimed |
| WO-2017081044-A1 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-05-18 | — | — | WO | claimed |
| EP-3373936-A1 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS | Bayer Pharma Aktiengesellschaft (DE) | 2018-09-19 | — | — | EP | disclosed |
| WO-2017081044-A1 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES FOR TREATING CHRONIC WOUNDS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-05-18 | — | — | WO | disclosed |
| EP-2234985-A1 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES AND USE THEREOF | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009080199-A1 | 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | WO | disclosed |